Analysts Viewpoint Adverum Biotechnologies Inc (ADVM) rating initates by Oppenheimer Adverum Biotechnologies Inc’s recent filing unveils that its CHIEF OPERATING OFFICER Soparkar Peter unloaded Company’s shares for reported $5920.0 on
Insiders Updates Adverum Biotechnologies Inc [NASDAQ: ADVM] Sees Decrease in Stock Value The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or